Positron Corporation (Positron) is a molecular imaging healthcare company providing nuclear medicine technologies and solutions that are reshaping the field of nuclear cardiology. The Company offers a range of products and services for nuclear imaging community. Through PET imaging systems, services and radiopharmaceutical solutions, Positron enables healthcare providers to more accurately diagnose disease and improve patient outcomes while practicing cost effective medicine. Attrius is a PET imaging system optimized for cardiology. Positron�s Attrius provides customers with state-of-the-art imaging technology for the diagnosis and treatment of cardiovascular disease. PosiStar is a clinical, technical and service customer care plan. Positron manufactures and processes radiopharmaceuticals at its cGMP (current good manufacturing practice) and NRC (Nuclear Regulatory Commission) licensed manufacturing facility. In January 2012, Positron acquired Manhattan Isotope Technology LLC. (MIT).